MitochondrialPreclinical Evidence

Humanin

Also known as: HN, Mitochondrial-derived peptide

Mitochondrially-encoded peptide with cytoprotective and anti-aging properties.

Benefits

6

Conditions

6

Evidence

Preclinical animal and cell culture studies+ studies

Source

Mitochondrially-encoded peptide

Overview

Mitochondrially-encoded peptide with cytoprotective and anti-aging properties.

Mechanism of Action

Protects against apoptosis via multiple pathways, enhances insulin sensitivity, reduces oxidative stress, protects neurons from β-amyloid toxicity, modulates mitochondrial function and cellular stress responses.

Key Benefits

  • Neuroprotection against Alzheimer's pathology
  • Enhances insulin sensitivity
  • Anti-apoptotic effects
  • Cardiovascular protection
  • Longevity promotion
  • Reduces oxidative stress

Clinical Applications

Alzheimer's diseaseType 2 diabetesCardiovascular diseaseAge-related diseasesMitochondrial dysfunctionNeurodegenerative disorders

Dosing Guidelines

Subcutaneous injection

Typical DoseResearch protocols vary
FrequencyDaily to weekly
DurationResearch stage

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Preclinical
Studies

Preclinical animal and cell culture studies

Summary

Strong preclinical evidence for neuroprotection and metabolic benefits. No human clinical trials. Promising target for age-related disease interventions.

Safety Information

Potential Side Effects

  • Unknown in humans

Contraindications

  • Pregnancy
  • Breastfeeding

Interactions

  • Unknown

Quick Facts

CategoryMitochondrial
SourceMitochondrially-encoded peptide
Legal StatusResearch compound, not available for human use
Gabriel Brain Score
85/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.